Warburg Effect Inversion: Adiposity shifts central primary metabolism in MCF‐7 breast cancer cells

  title={Warburg Effect Inversion: Adiposity shifts central primary metabolism in MCF‐7 breast cancer cells},
  author={Carla Lu{\'i}s and Fernanda O Duarte and Isabel Faria and Ivana Jarak and Pedro Fontes Oliveira and Marco G. Alves and Raquel A Soares and R{\'u}ben Fernandes},
  journal={Life Sciences},

Figures and Tables from this paper

The Impact of Metabolic Syndrome and Type 2 Diabetes Mellitus on Prostate Cancer

The impact of metabolic disorders in PCa’s aggressiveness state and metabolism is evaluated, finding that Metabolic Syndrome and Type 2 Diabetes Mellitus influence on PCa prognosis appears to have an inverse effect.

Interaction between adipose tissue and cancer cells: role for cancer progression.

Recent advances in the understanding of the molecular mechanisms linking adipose tissue with cancer progression are reported in order to propose new therapeutic strategies based on pharmacological or nutritional intervention.

Adipocyte-Derived Extracellular Vesicles Promote Prostate Cancer Cell Aggressiveness by Enabling Multiple Phenotypic and Metabolic Changes

It is found that EVs derived from 3T3-L1 adipocytes could affect PC3 and DU145 PCa cell traits, inducing increased proliferation, migration and invasion and demonstrating that EV-mediated crosstalk exists between adipocytes and PCa, driving tumor aggressiveness.

Flavonoids against the Warburg phenotype—concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism

Individualised profiling and patient stratification are presented as powerful tools for implementing targeted ‘anti-Warburg’ measures in the context of predictive, preventive and personalised medicine.

A STAT3 of Addiction: Adipose Tissue, Adipocytokine Signalling and STAT3 as Mediators of Metabolic Remodelling in the Tumour Microenvironment

The central role played by the crosstalk between the transcriptional and mitochondrial roles of STAT3 to promote survival and further oncogenesis within the tumour microenvironment is examined with a particular focus on adipose-breast cancer interactions.

A “Weird” Mitochondrial Fatty Acid Oxidation as a Metabolic “Secret” of Cancer

This article discusses how mFAO can escape normal regulation under certain conditions and be overactivated and proposes the idea that the altered mitochondrial redox state and/or inhibited Krebs cycle at certain segments may link mitochondrial β-oxidation to the citrate-malate shuttle instead to the Krebs Cycle.

Enhanced 3T3-L1 Differentiation into Adipocytes by Pioglitazone Pharmacological Activation of Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ)

It is concluded that pioglitazone enhanced adipocyte differentiation and secretome production, making this secretome an excellent adiposity study model and an improved method for adipocyte secretomeproduction that is suitable for experimental biology studies and that could help with the understanding of the molecular mechanisms underlying adiposity influence in other cells.

Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway

It is suggested that shikonin not only inhibits PKM2 intracellularly but also reduces glycolytic flux and increases cisplatin sensitivity through the exosomal pathway.

Perinatal Nutritional and Metabolic Pathways: Early Origins of Chronic Lung Diseases

A comprehensive overview of the current knowledge regarding the impact of perinatal metabolism and nutrition on the lung and beyond the cardiopulmonary system as well as possible mechanisms determining the individual susceptibility to CLD early in life is provided.

Over-Reduced State of Mitochondria as a Trigger of “β-Oxidation Shuttle” in Cancer Cells

It is proposed the idea that many peculiarities of the cancer cell metabolism are easier to explain considering the incomplete combustion of fatty acids in the cancerous mitochondria due to their over-reduced redox state, and the role of the β-oxidation shuttle and its contribution to redox-altered cancer metabolism provides a new direction for the development of future anticancer strategies.



Obesity, metabolism and the microenvironment: Links to cancer

Obesity-driven changes in both the normal and tumor microenvironment, alterations in metabolism, and release of signaling molecules such as endocrine, growth, and inflammatory mediators will be highlighted and the effects of the timing of obesity onset or particular “windows of susceptibility,” with a focus on breast cancer etiology are discussed.

Adipocyte Secretome Increases Radioresistance of Malignant Melanocytes by Improving Cell Survival and Decreasing Oxidative Status

In vitro adipocyte-released factors protected B16-F10 malignant melanocytes from both oxidative stress and loss of viability triggered by radiation, enhancing the radioresistant phenotype of these cells with a concomitant activation of the AKT signaling pathway.

27-Hydroxycholesterol Links Hypercholesterolemia and Breast Cancer Pathophysiology

It is shown that 27-hydroxycholesterol (27HC), a primary metabolite of cholesterol and an ER and liver X receptor (LXR) ligand, increases ER-dependent growth and LXR-dependent metastasis in mouse models of breast cancer.

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth

It is shown that primary human omental adipocytes promote homing, migration and invasion of ovarian cancer cells, and that adipokines including interleukin-8 (IL-8) mediate these activities, and adipocytes provide fatty acids for rapid tumor growth.

Metabolic Pathways of the Warburg Effect in Health and Disease: Perspectives of Choice, Chain or Chance

This review explores the current understanding of the Warburg effect’s role in cancer, diabetes and ageing and highlights how it can be regulated through a chain of oncogenic events, as a chosen response to impaired glucose metabolism or by chance acquisition of genetic changes associated with ageing.

Diabetes and cancer: two diseases with obesity as a common risk factor

The relationship between diabetes, obesity and cancer is examined, and the potential underlying causes of increased cancer risk in individuals with diabetes are investigated.

The underlying basis for obesity: relationship to cancer.

  • G. Bray
  • Biology, Medicine
    The Journal of nutrition
  • 2002
Of interest is that experimental animals lacking aromatase or the estrogen receptor alpha are obese and have an increased risk of developing colon cancer in response to carcinogenic drugs.

The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma

In this alternative model of tumorigenesis, the epithelial cancer cells instruct the normal stroma to transform into a wound-healing stroma, providing the necessary energy-rich micro-environment for facilitating tumor growth and angiogenesis, explaining its powerful predictive value.

Molecular links between obesity and breast cancer.

The evidence in the literature that test mechanism-based hypotheses which attempt to provide a molecular basis for a causal link between obesity and breast cancer risk, particularly the effects of metabolic syndrome and insulin resistance, peripheral estrogen aromatization in adipose tissue, and direct effect of adipokines are reviewed.